Table 2. National and regional estimates of rotavirus burden, rotavirus vaccine effectiveness and economic impact for a cohort of children in Nigeria over the first five years of life.
| Burden (RV deaths / 1,000 births) | RV Deaths / year | RV Deaths Averted / year | Vaccine Benefits (RV deaths averted/1,000 births) | Vaccine % Reduction | Averted Costs of Illness (2019 US$ / 1,000 births) | |
|---|---|---|---|---|---|---|
| NATIONAL | 7.44 (5.49; 9.89) | 47,898 (35,361; 63,703) | 6,454 (3,960; 9,721) | 1.00 (0.61; 1.51) | 13 (9; 18) | 1,066 (733; 1,428) |
| REGION | ||||||
| North Central | 5.98 (4.36; 7.98) | 6,672 (4,865; 8,905) | 1,102 (672; 1,650) | 0.99 (0.60; 1.48) | 17 (11; 22) | 1,213 (825; 1,615) |
| North East | 9.27 (6.84; 12.31) | 9,654 (7,123; 12,815) | 872 (539; 1,320) | 0.84 (0.52; 1.27) | 9 (6; 12) | 349 (239; 468) |
| North West | 11.54 (8.52; 15.29) | 22,846 (16,864; 30,273) | 1,460 (891; 2,181) | 0.74 (0.45; 1.10) | 6 (4; 9) | 399 (271; 531) |
| South East | 4.69 (3.44; 6.19) | 2,478 (1,818; 3,269) | 873 (535; 1,317) | 1.65 (1.01; 2.49) | 35 (24; 47) | 1,637 (1,118; 2,180) |
| South South | 3.43 (2.52; 4.54) | 2,495 (1,838; 3,305) | 714 (439; 1,076) | 0.98 (0.60; 1.48) | 29 (20; 38) | 2,138 (1,463; 2,859) |
| South West | 4.42 (3.25; 5.88) | 4,634 (3,404; 6,156) | 1,432 (880; 2,151) | 1.37 (0.84; 2.05) | 31 (21; 41) | 2,313 (1,580; 3,069) |